1. Home
  2. GSHD vs GHRS Comparison

GSHD vs GHRS Comparison

Compare GSHD & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goosehead Insurance Inc.

GSHD

Goosehead Insurance Inc.

HOLD

Current Price

$40.59

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$21.48

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSHD
GHRS
Founded
2003
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
947.2M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
GSHD
GHRS
Price
$40.59
$21.48
Analyst Decision
Buy
Strong Buy
Analyst Count
12
8
Target Price
$72.50
$41.38
AVG Volume (30 Days)
381.2K
252.6K
Earning Date
04-22-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$365,304,000.00
N/A
Revenue This Year
$16.40
N/A
Revenue Next Year
$18.53
N/A
P/E Ratio
$40.72
N/A
Revenue Growth
16.15
N/A
52 Week Low
$39.64
$9.52
52 Week High
$114.76
$24.66

Technical Indicators

Market Signals
Indicator
GSHD
GHRS
Relative Strength Index (RSI) 39.34 62.50
Support Level N/A $12.41
Resistance Level $46.40 $24.66
Average True Range (ATR) 2.86 1.48
MACD -0.51 0.08
Stochastic Oscillator 3.26 68.22

Price Performance

Historical Comparison
GSHD
GHRS

About GSHD Goosehead Insurance Inc.

Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: